Advised Alpine Bird Manufacturing on the sale of its 50% limited partnership interest in Action Manufacturing LP (Australasia’s largest vehicle specialiser) to Tourism Holdings Limited.
Advised Clinician Holdings on its latest investment round, raising US$5.4m at a pre-money valuation of more than US$40m.
Advised the investors on the latest investment round for Helius Therapeutics – an additional $15m invested in Series D, (increasing total investment to date to more than $45m).
Advised the lead investor syndicate on the latest investment round for Nyriad Limited which raised in excess of $33m of new equity (inclusive of note conversion).
Advising Covid-19 Vaccine Corporation (and its investors) on capital raising and licensing arrangements ($4.3m invested to date).
Represented Massey Ventures in connection with the sale of the New Zealand Veterinary Pathology (NZVP) business to a wholly owned subsidiary of IDEXX Laboratories Inc (a US listed company and leading provider of veterinary diagnostic services globally). My involvement included an active role in the commercial negotiations and representing Massey Ventures (as a 36% shareholder) […]
Advised Pureland Dairy (owned by a BVI vehicle representing Asian investors) on the acquisition of the assets of Kaimai Cheese Factory.
Advised Milford Asset Management on its $2m convertible loan investment in Straker Translations, a rapidly growing and innovative New Zealand company eyeing a NZX listing in the next 6 to 18 months. Click here to read article
Advised Complete Entertainment Services on the sale of its business to The Warehouse Limited.
Advised Kea Campers on its sale transaction with Tourism Holdings Limited, as part of a $69m campervan merger. Click here to read NZ Herald article